Table 1. Body/metabolic parameters at 32 weeks of age (n = 6–12), *P < 0.05, **P < 0.01, compared with non-diabetic littermates.
CC-ctrl | CC-T1D | HC-ctrl | HC-T1D | |
---|---|---|---|---|
Body weight (g) | 26.97 ± 0.37 | 23.79 ± 0.62** | 26.84 ± 0.83 | 24.20 ± 0.54** |
Kidney/Body (% total) | 0.85 ± 0.39 | 0.80 ± 0.74 | 0.76 ± 0.70 | 0.75 ± 0.53 |
Liver/Body (% total) | 5.42 ± 0.24 | 5.48 ± 0.12 | 5.35 ± 0.19 | 5.88 ± 0.19 |
Epididymal mass (% total) | 1.59 ± 0.11 | 1.48 ± 0.15 | 2.12 ± 0.20# | 1.33 ± 0.13** |
Retroperitoneal fat (% total) | 0.54 ± 0.05 | 0.46 ± 0.06 | 0.81 ± 0.07## | 0.39 ± 0.05** |
Glucose (mmol/L) | 14.11 ± 0.46 | 22.23 ± 0.97** | 15.43 ± 0.51 | 20.28 ± 1.10** |
HbA1c (%) | 4.51 ± 0.06 | 5.85 ± 0.24** | 4.36 ± 0.11 | 5.65 ± 0.25** |
HbA1c (mmol/mol) | 25.76 ± 0.82 | 40.44 ± 2.97 ** | 24.15 ± 2.00 | 38.21 ± 3.02 ** |
Serum insulin (pmol/L) | 67.72 ± 1.97 | 8.46 ± 3.10** | 21.10 ± 5.10# | 4.57 ± 2.30** |
Serum NEFA (mmol/L) | 0.81 ± 0.06 | 1.06 ± 0.10 | 1.06 ± 0.23# | 1.66 ± 0.18** |
Serum triglycerides (mmol/L) | 0.25 ± 5.54 | 0.67 ± 2.01* | 0.93 ± 3.49***## | 0.43 ± 0.72** |
Serum Creatinine (μmol/L) | 24.00 ± 0.55 | 28.67 ± 1.28* | 28.00 ± 0.72* | 28.00 ± 1.844* |
Urine volume (mL/24 h) | 0.50 ± 0.11 | 1.67 ± 0.57* | 0.89 ± 0.16 | 1.62 ± 0.34* |
24 h urinary albumin (mg/24 h) | 7.71 ± 1.87 | 31.01 ± 7.00* | 30.07 ± 3.87# | 42.66 ± 7.55 * |
#P < 0.05, ##P < 0.01. Compared with the control mice with the same treatment, results are expressed as mean ± SEM, n = 6–12.